# LAKESHORE BIOTECHNOLOGY

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lakeshore-biotechnology

- Industry: Biotechnology
- Headquarters: Fuzhou, China
- Total disclosed funding: $31M
- Latest round: Angel (Jan 10, 2022)
- Investors on record: 2

## About

Based in Fuzhou, China, and established in 2021, LAKESHORE BIOTECHNOLOGY is a biopharmaceutical company that focuses on developing cells gene therapy drugs to treat cancer, genetic diseases, and immune diseases. The company's CTO is professor Liang Desheng's team from Central South University, who has more than 20 years experience in gene and cells technologies.


The company will develop three platforms, targeted modification technology R&D platform, delivery technology R&D platform, and targeted modified drug production platform. The company will also develop cell gene therapy drugs to treat cancer, genetic diseases, and immune diseases.

## Funding rounds

- Angel, Jan 10, 2022, $31M — Legend Capital, Legend Holdings

## Investors

- Legend Capital — Angel
- Legend Holdings — Angel